Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and aedes aegypti mosquitoes

Vector-Borne and Zoonotic Diseases

Volumn 11, Issue 6, 2011, Pages 665-674

  Engel, Amber R ^a   Mitzel, Dana N ^b   Hanson, Christopher T ^a   Wolfinbarger, James B ^b   Bloom, Marshall E ^b   Pletnev, Alexander G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aedes aegypti; Dengue; Flavivirus; Ixodes scapularis; Live attenuated vaccine; Tick borne encephalitis virus

Indexed keywords

LIVE VACCINE; NONSTRUCTURAL PROTEIN 5; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

AEDES AEGYPTI; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; DENGUE VIRUS; DISEASE TRANSMISSION; INSECT CELL; IXODES SCAPULARIS; LARVA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VERO CELL; VIROGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

AEDES; ANIMALS; CELL LINE; DENGUE VIRUS; ENCEPHALITIS VIRUSES, TICK-BORNE; IXODES; REASSORTANT VIRUSES; RNA, VIRAL; VIRUS REPLICATION;

AEDES AEGYPTI; ARTHROPODA; FLAVIVIRUS; IXODES SCAPULARIS; IXODIDA; MUS; TICK-BORNE ENCEPHALITIS VIRUS;

EID: 79959449636     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2010.0179     Document Type: Article

References (42)

1. Andersson, CR, Vene, S, Insulander, M, Lindquist, L, et al. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 2010; 28:2827-2831.
2. Bender, A, Jager, G, Scheuerer, W, Feddersen, B, et al. Two severe cases of tick-borne encephalitis despite complete active vaccination - the significance of neutralizing antibodies. J Neurol 2004; 251:353-354. (Pubitemid 38387158)
3. Best, SM, Morris, KL, Shannon, JG, Robertson, SJ, et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 2005; 79:12828-12839. (Pubitemid 41433202)
4. Bhatt, TR, Crabtree, MB, Guirakhoo, F, Monath, TP, et al. Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg 2000; 62:480-484. (Pubitemid 32164755)
5. Blaney, JE, Jr., Hanson, CT, Firestone, CY, Hanley, KA, et al. Genetically modified, live attenuated dengue virus type 3 vaccine candidates. Am J Trop Med Hyg 2004; 71:811-821. (Pubitemid 40075635)
6. Blaney, JE, Jr., Sathe, NS, Hanson, CT, Firestone, CY, et al. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1. Virol J 2007; 4:23.
7. Charlier, N, Davidson, A, Dallmeier, K, Molenkamp, R, et al. Replication of not known vector flaviviruses in mosquito cells is restricted by intracellular host factors rather than by the viral envelope proteins. J Gen Virol 2010; 91:1693-1697.
8. Engel, AR, Rumyantsev, AA, Maximova, OA, Speicher, JM, et al. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3′ non-coding region of the genome. Virology 2010; 405:243-252.
9. Grgic-Vitek, M, Avsic-Zupanc, T, Klavs, I. Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis. Vaccine 2010; 28:7396-7400.
10. Gritsun, TS, Lashkevich, VA, Gould, EA. Tick-borne encephalitis. Antiviral Res 2003; 57:129-146. (Pubitemid 36254727)
11. Gubler, DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480-496. (Pubitemid 28379096)
12. Halstead, S, Jacobson, J. Japanese encephalitis vaccines. In: Plotkin, S, Orenstein, W, Offit, P, eds. Vaccines. Philadelphia: Elsevier, 2008; pp. 311-352.
13. Hanley, KA, Goddard, LB, Gilmore, LE, Scott, TW, et al. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors. Vector Borne Zoonot Dis 2005; 5:1-10. (Pubitemid 41309107)
14. Hanley, KA, Manlucu, LR, Gilmore, LE, Blaney, JE, Jr., et al. A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. Virology 2003; 312:222-232. (Pubitemid 36918474)
15. Il'enko, VI, Smorodincev, AA, Prozorova, IN, Platonov, VG. Experience in the study of a live vaccine made from the TP-21 strain of Malayan Langat virus. Bull World Health Organ 1968; 39:425-431.
16. Johnson, BW, Chambers, TV, Crabtree, MB, Arroyo, J, et al. Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med Vet Entomol 2003; 17:235-243. (Pubitemid 37123924)
17. Johnson, BW, Chambers, TV, Crabtree, MB, Guirakhoo, F, et al. Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am J Trop Med Hyg 2004; 70:89-97. (Pubitemid 39220522)
18. Kleiter, I, Jilg, W, Bogdahn, U, Steinbrecher, A. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination. Infection 2007; 35:26-29. (Pubitemid 46295038)
19. Kuno, G. Host range specificity of flaviviruses: correlation with in vitro replication. J Med Entomol 2007; 44:93-101. (Pubitemid 46381996)
20. Kunze, U. Tick-borne encephalitis - a European health challenge. Conference report of the 8th meeting of the International Scientific Working Group on Tick-borne encephalitis (ISW TBE). Wien Med Wochenschr 2006; 156:376-378. (Pubitemid 44174332)
21. Lawrie, CH, Uzcategui, NY, Armesto, M, Bell-Sakyi, L, et al. Susceptibility of mosquito and tick cell lines to infection with various flaviviruses. Med Vet Entomol 2004; 18:268-274. (Pubitemid 39260349)
22. Lindenbach, B, Thiel, H, Rice, C. Flaviviridae: The viruses and their replication. In: Knipe, D, Howley, P, eds. Fields Virology, 5th edition. Philadelphia: Lippincott-Raven Publishers, 2007:1101-1152.
23. Lotric-Furlan, S, Avsic-Zupanc, T, Strle, F. Tick-borne encephalitis after active immunization. Int J Med Microbiol 2008; 298:309-313.
24. Maximova, OA, Ward, JM, Asher, DM, St. Claire, M, et al. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates. J Virol 2008; 82:5255-5268. (Pubitemid 351705234)
25. McElroy, KL, Tsetsarkin, KA, Vanlandingham, DL, Higgs, S. Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3′ non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut. Am J Trop Med Hyg 2006; 75:1158-1164. (Pubitemid 351627501)
26. Mitzel, DN, Wolfinbarger, JB, Long, RD, Masnick, M, et al. Tick-borne flavivirus infection in Ixodes scapularis larvae: development of a novel method for synchronous viral infection of ticks. Virology 2007; 365:410-418. (Pubitemid 47223315)
27. Monath, TP. Yellow fever vaccine. Expert Rev Vaccines 2005; 4:553-574. (Pubitemid 41297302)
28. Munderloh, UG, Liu, Y, Wang, M, Chen, C, et al. Establishment, maintenance and description of cell lines from the tick Ixodes scapularis. J Parasitol 1994; 80:533-543. (Pubitemid 24268762)
29. Nosek, J, Kozuch, O. Replication of tick-borne encephalitis (TBE) virus in ticks Dermacentor marginatus. Angew Parasitol 1985; 26:97-101. (Pubitemid 15054837)
30. Pletnev, AG, Bray, M, Hanley, KA, Speicher, J, et al. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys andin mosquitoes. J Virol 2001; 75:8259-8267. (Pubitemid 32743698)
31. Pletnev, AG, Men, R. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc Natl Acad Sci U S A 1998; 95:1746-1751. (Pubitemid 28103465)
32. Plisek, S, Honegr, K, Beran, J. TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area - impact on current recommendations for immunization of high-risk groups. Vaccine 2008; 26:301-304.
33. Randolph, SE. Tick-borne encephalitis incidence in Central and Eastern Europe: consequences of political transition. Microbes Infect 2008; 10:209-216.
34. Rumyantsev, AA, Chanock, RM, Murphy, BR, Pletnev, AG. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Vaccine 2006; 24:133-143. (Pubitemid 41753000)
35. Ruzek, D, Bell-Sakyi, L, Kopecky, J, Grubhoffer, L. Growth of tick-borne encephalitis virus (European subtype) in cell lines from vector and non-vector ticks. Virus Res 2008; 137:142-146.
36. Schrauf, S, Mandl, CW, Bell-Sakyi, L, Skern, T. Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells. J Virol 2009; 83:11201-11210.
37. Schwaiger, M, Cassinotti, P. Development of a quantitative realtime RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA. J Clin Virol 2003; 27:136-145. (Pubitemid 37329334)
38. Stiasny, K, Holzmann, H, Heinz, FX. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine 2009; 27:7021-7026.
39. Troyer, JM, Hanley, KA, Whitehead, SS, Strickman, D, et al. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg 2001; 65:414-419. (Pubitemid 33134571)
40. Varma, MG, Smith, CE. Multiplication of Langat virus in the tick Ixodes ricinus. Acta Virol 1972; 16:159-167.
41. Whitehead, SS, Hanley, KA, Blaney, JE, Jr., Gilmore, LE, et al. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine 2003; 21:4307-4316. (Pubitemid 37138698)
42. Wright, PF, Ankrah, S, Henderson, SE, Durbin, AP, et al. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. Vaccine 2008; 26:882-890.